Sunday, February 16, 2020

Sunday, February 16, 2020

Latest News

U.S. FDA: Trump Administration takes historic steps to lower U.S. prescription drug prices

Proposed rule could allow certain prescription drugs to be imported from Canada; draft guidance explains how manufacturers could import drugs, biological products originally intended for sale in another country

U.S. FDA: Statement on low-cost biosimilar and interchangeable protein products

Ensuring an efficient pathway to bring potentially lower-cost biosimilar and interchangeable protein products to market is key for expanding access to these products and increasing competition, ultimately helping American patients.

U.S. FDA: Statement on efforts to help make development of biosimilar and interchangeable insulin products more efficient

Access to affordable insulin can be a matter of life and death for Americans with diabetes. If not appropriately treated, diabetes can lead to serious and life-threatening complications, including heart disease, organ failure and blindness.

U.S. FDA: Statement on new testing results, including low levels of impurities in ranitidine drugs

Americans deserve to have confidence in the quality of drugs the U.S. Food and Drug Administration regulates – from the prescription medicines they take to the over-the-counter (OTC) products they use in their daily lives.

FDA Health News